8-KLeadership Changes

DANAHER CORP /DE/ 8-K Report, Executive Changes (Feb 22, 2017)

Filed February 22, 2017For Securities:DHR

Summary

Danaher Corporation (DHR) filed an 8-K on February 21, 2017, announcing a change to its Board of Directors. The Board's size was increased from eleven to twelve members, and Dr. Raymond C. Stevens was appointed to fill this new vacancy. Dr. Stevens's term will extend until the 2017 annual shareholder meeting. He has been deemed independent under NYSE listing standards and will receive standard compensation for non-employee directors, as previously disclosed in their Form 10-K. This appointment signifies an expansion of the Board, potentially to accommodate new strategic directions or governance needs. Investors should note that Dr. Stevens has no disclosed related-party transactions or prior arrangements influencing his selection, indicating a straightforward addition to the directorial team.

Key Highlights

  • 1Danaher Corporation increased its Board of Directors size from 11 to 12 members.
  • 2Dr. Raymond C. Stevens was appointed to the newly created vacancy on the Board.
  • 3Dr. Stevens's term on the Board will expire at the 2017 annual shareholder meeting.
  • 4Dr. Stevens has been classified as independent under New York Stock Exchange listing standards.
  • 5As a non-employee director, Dr. Stevens will receive compensation consistent with other independent directors.
  • 6There are no disclosed understandings or arrangements between Dr. Stevens and other parties regarding his appointment.
  • 7Dr. Stevens has no transactions requiring disclosure under Item 404(a) of Regulation S-K.

Frequently Asked Questions

Dr. Raymond C. Stevens is a professor who was appointed to Danaher Corporation's Board of Directors to fill a newly created vacancy. His appointment aims to expand the board's size and likely brings his expertise to the company's governance. There were no specific prior arrangements or transactions disclosed that led to his selection, indicating a standard appointment process.

Increasing the board size from eleven to twelve members can provide greater capacity for oversight, strategic planning, and committee assignments. It might also signal the company's readiness to expand its operations or adapt to new challenges. For investors, it generally suggests a commitment to robust corporate governance.

This filing primarily concerns a change in board composition, not a major financial transaction or operational shift. While a well-qualified and independent board member can contribute positively to long-term strategy and oversight, this specific appointment is unlikely to have a direct, immediate impact on DHR's stock price. Investors should consider it as part of the company's ongoing governance and strategic evolution.